Completed PHASE4 INTERVENTIONAL 1-arm NCT00611195

Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI

Impact of Remifentanil Administration on Laryngeal Reflex Responses in Pediatric Patients With Upper Respiratory Anesthetized With Propofol

Sponsor: Thomas Erb

Conditions Upper Respiratory Infections

Interventions propofol, remifentanil

Updated 5 times since 2017 Last updated: Oct 29, 2015 Started: Jan 31, 2008 Primary completion: Oct 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00611195, this PHASE4 trial focuses on Upper Respiratory Infections and remains completed. Sponsored by Thomas Erb, it has been updated 5 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Thomas Erb

Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland